• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺功能亢进症患者外科手术治疗中原发性甲状腺疾病的术前和术后评估。

Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism.

机构信息

Department of Endocrinology and Metabolism, Ankara Ataturk Education and Research Hospital, Bilkent, Ankara, Turkey.

出版信息

Endocr Pract. 2010 Jan-Feb;16(1):7-13. doi: 10.4158/EP09138.OR.

DOI:10.4158/EP09138.OR
PMID:20180280
Abstract

OBJECTIVE

To evaluate the occurrence of thyroid disease in patients undergoing parathyroidectomy for primary hyperparathyroidism.

METHODS

In this case series, records of all patients with a diagnosis of primary hyperparathyroidism who underwent parathyroidectomy between January 2005 and December 2008 in our clinic were analyzed retrospectively. Preoperatively, all patients were evaluated with ultrasonography and parathyroid scintigraphy; when needed, thyroid scintigraphy and ultrasound-guided fine-needle aspiration biopsy (FNAB) were used. All patients underwent standard neck exploration. Postoperative histopathologic findings of thyroid tissue were classified as nodular/multinodular hyperplasia, Hashimoto thyroiditis, papillary thyroid carcinoma, or normal.

RESULTS

Fifty-one women and 9 men were included. In the 60 patients, preoperative ultrasonography revealed thyroiditis (without nodules) in 13 (22%), a solitary nodule in 9 (15%) (coexistent with thyroiditis in 7 patients), multinodular goiter in 24 (40%) (coexistent with thyroiditis in 5 patients), and normal findings in 14 (23%). Rates of thyroiditis and nodular goiter were 42% and 55%, respectively. Collectively, prevalence of thyroid disease was 77%. Total thyroidectomy was performed in 27 patients, and hemithyroidectomy was performed in 15 patients. Indications for total thyroidectomy were nondiagnostic or suspicious FNAB results in 5 patients, hyperthyroidism in 4 patients, ultrasonography findings in 11 patients, and intraoperatively recognized suspicious nodularity in 7 patients. Postoperatively, thyroid carcinoma was diagnosed in 9 patients (15%).

CONCLUSIONS

Thyroid disease, particularly thyroid carcinoma, is common in patients with primary hyperparathyroidism. This association should be considered when selecting the surgical procedure. Intraoperative evaluation of the thyroid is as important as preoperative evaluation with ultrasonography and FNAB in patients with thyroid disease and primary hyperparathyroidism.

摘要

目的

评估甲状旁腺切除术治疗原发性甲状旁腺功能亢进症患者的甲状腺疾病发生率。

方法

在本病例系列研究中,回顾性分析了 2005 年 1 月至 2008 年 12 月期间在我院接受甲状旁腺切除术的所有原发性甲状旁腺功能亢进症患者的病历。所有患者术前均行超声检查和甲状旁腺闪烁扫描;必要时行甲状腺闪烁扫描和超声引导下细针抽吸活检(FNAB)。所有患者均行标准颈部探查。术后甲状腺组织的组织病理学发现分为结节/多结节性增生、桥本甲状腺炎、甲状腺乳头状癌或正常。

结果

共纳入 60 例患者,其中 51 例女性,9 例男性。在 60 例患者中,术前超声检查发现 13 例(22%)甲状腺炎(无结节)、9 例(15%)单发结节(7 例合并甲状腺炎)、24 例(40%)多结节性甲状腺肿(5 例合并甲状腺炎)和 14 例(23%)正常。甲状腺炎和结节性甲状腺肿的发生率分别为 42%和 55%。甲状腺疾病总患病率为 77%。27 例行全甲状腺切除术,15 例行半甲状腺切除术。5 例患者因 FNAB 结果不明确或可疑、4 例患者因甲状腺功能亢进、11 例患者因超声检查结果、7 例患者因术中发现可疑结节而行全甲状腺切除术。术后 9 例(15%)诊断为甲状腺癌。

结论

原发性甲状旁腺功能亢进症患者中甲状腺疾病,特别是甲状腺癌较为常见。在选择手术方式时应考虑到这种关联。对于甲状腺疾病合并原发性甲状旁腺功能亢进症患者,术中评估与超声和 FNAB 术前评估同样重要。

相似文献

1
Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism.甲状旁腺功能亢进症患者外科手术治疗中原发性甲状腺疾病的术前和术后评估。
Endocr Pract. 2010 Jan-Feb;16(1):7-13. doi: 10.4158/EP09138.OR.
2
Preoperative evaluation of thyroid pathology in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进患者甲状腺病变的术前评估
Thyroid. 2007 Jan;17(1):59-62. doi: 10.1089/thy.2006.0182.
3
Impact of preoperative thyroid ultrasonography on the surgical management of primary hyperparathyroidism.术前甲状腺超声检查对原发性甲状旁腺功能亢进症手术治疗的影响。
Br J Surg. 2008 Aug;95(8):957-60. doi: 10.1002/bjs.6097.
4
Thyroid evaluation in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进患者的甲状腺评估
Endocr J. 2005 Apr;52(2):177-82. doi: 10.1507/endocrj.52.177.
5
Role of cervical ultrasound in detecting thyroid pathology in primary hyperparathyroidism.颈超声在原发性甲状旁腺功能亢进症甲状腺病变中的作用。
J Surg Res. 2014 Aug;190(2):575-8. doi: 10.1016/j.jss.2014.03.038. Epub 2014 Mar 19.
6
Concomitant thyroid lesions in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者的同时存在的甲状腺病变。
Asian J Surg. 2017 Sep;40(5):338-344. doi: 10.1016/j.asjsur.2015.10.006. Epub 2016 Jan 11.
7
Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography.甲状腺细针穿刺活检:甲状腺触诊与超声检查的比较
Endocr Pract. 2002 Jul-Aug;8(4):282-6. doi: 10.4158/EP.8.4.282.
8
Surgical management of primary hyperparathyroidism.原发性甲状旁腺功能亢进症的外科治疗
Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4225-4232. doi: 10.1007/s00405-017-4776-4. Epub 2017 Oct 16.
9
Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy?所有接受甲状旁腺切除术的患者术前都要进行甲状腺超声检查吗?
J Surg Res. 2009 Aug;155(2):254-60. doi: 10.1016/j.jss.2008.09.012. Epub 2008 Dec 4.
10
Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease.原发性甲状旁腺功能亢进症合并甲状腺疾病的术前定位及微创治疗
J Zhejiang Univ Sci B. 2007 Sep;8(9):626-31. doi: 10.1631/jzus.2007.B0626.

引用本文的文献

1
CO-EXISTING HASHIMOTO'S THYROIDITIS DOES NOT AFFECT BONE METABOLISM IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.合并存在的桥本甲状腺炎不影响原发性甲状旁腺功能亢进患者的骨代谢。
Acta Endocrinol (Buchar). 2023 Apr-Jun;19(2):187-194. doi: 10.4183/aeb.2023.187. Epub 2023 Oct 27.
2
Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study.甲状腺乳头状癌合并甲状旁腺功能亢进症的长期治疗效果:一项单中心病例对照研究。
Biomed J. 2020 Feb;43(1):53-61. doi: 10.1016/j.bj.2019.05.010. Epub 2020 Feb 27.
3
The role of ultrasound in the diagnosis of the coexistence of primary hyperparathyroidism and non-medullary thyroid carcinoma.
超声在原发性甲状旁腺功能亢进症与非髓样甲状腺癌共存诊断中的作用
BMC Med Imaging. 2019 Jan 18;19(1):7. doi: 10.1186/s12880-019-0306-8.
4
Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer.症状性原发性甲状旁腺功能亢进作为分化型甲状腺癌的一个危险因素
J Thyroid Res. 2018 Nov 18;2018:9461079. doi: 10.1155/2018/9461079. eCollection 2018.
5
Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases.甲状腺与甲状旁腺合并疾病的外科治疗:4882例病例分析
Eur Arch Otorhinolaryngol. 2017 Feb;274(2):997-1004. doi: 10.1007/s00405-016-4303-z. Epub 2016 Sep 12.
6
A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.18F-氟胆碱PET/CT、超声检查及123I/99mTc-甲氧基异丁基异腈双相双同位素闪烁扫描术在原发性或继发性甲状旁腺功能亢进症中功能亢进甲状旁腺术前定位的初步比较:甲状腺异常的影响
Medicine (Baltimore). 2015 Oct;94(41):e1701. doi: 10.1097/MD.0000000000001701.
7
Is primary hyperparathyroidism a risk factor for papillary thyroid cancer? An exemplar study and literature review.原发性甲状旁腺功能亢进症是甲状腺乳头状癌的危险因素吗?一项范例研究及文献综述。
Int Arch Otorhinolaryngol. 2015 Jan;19(1):42-5. doi: 10.1055/s-0034-1396520. Epub 2014 Dec 8.
8
To do or not to do: neck ultrasound and the detection of thyroid pathology in patients with primary hyperparathyroidism.做还是不做:原发性甲状旁腺功能亢进患者的颈部超声检查与甲状腺病变检测
J Surg Res. 2014 Aug;190(2):415-6. doi: 10.1016/j.jss.2014.05.062. Epub 2014 May 24.
9
Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves' hyperthyroidism.在一名同时患有原发性甲状旁腺功能亢进和格雷夫斯甲状腺功能亢进的患者中偶然发现伴有BRAFV600E突变的甲状腺乳头状癌。
BMJ Case Rep. 2014 May 30;2014:bcr2013203436. doi: 10.1136/bcr-2013-203436.
10
Parathyroid incidentalomas detected during thyroid ultrasonography and effect of chronic thyroiditis on false positive parathyroid lesions.甲状腺超声检查中偶然发现的甲状旁腺腺瘤及慢性甲状腺炎对甲状旁腺病变假阳性的影响。
Endocrine. 2012 Dec;42(3):616-21. doi: 10.1007/s12020-012-9700-5. Epub 2012 May 23.